Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

Saved in:
Bibliographic Details
Published in:Journal of hematology and oncology 2024-10, Vol.17 (1), p.98-1, Article 98
Main Authors: Alcantara, Marion, Chevrier, Marion, Jardin, Fabrice, Schmitt, Anna, Houillier, Caroline, Oberic, Lucie, Chinot, Olivier, Morschhauser, Franck, Peyrade, Frédéric, Houot, Roch, Hoang-Xuan, Khê, Ghesquieres, Hervé, Soussain, Carole
Format: Article
Language:English
Subjects:
Comparative analysis
Immunotherapy
Lymphomas
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1756-8722
1756-8722
DOI:10.1186/s13045-024-01620-y